These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 381138)

  • 21. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelations between plasma renin activity, aldosterone, and sympathetic nervous system activity in essential hypertension.
    Jindra A; Ripka O; Savlíková J; Peleska J; Linhartová J; Ort J
    Acta Biol Med Ger; 1978; 37(10):1543-50. PubMed ID: 752207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of the sympathetic nervous system in the pathogenesis of arterial hypertension in rats with genetically conditioned hypertension].
    Przybylski J; Januszewicz P
    Acta Physiol Pol; 1978; 29 Suppl 17():21-31. PubMed ID: 751460
    [No Abstract]   [Full Text] [Related]  

  • 24. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension in children. II. The pathogenetic mechanisms involved in arterial hypertension and the therapeutic correlates].
    Moraru D
    Pediatrie (Bucur); 1992; 41(3):46-59. PubMed ID: 1327233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of obesity-related hypertension.
    Lamounier-Zepter V; Bornstein SR; Ehrhart-Bornstein M
    Horm Metab Res; 2004 Jun; 36(6):376-80. PubMed ID: 15241727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiology of hypertension].
    Lydtin H
    Z Allgemeinmed; 1975 Nov; 51(33):1511-8. PubMed ID: 1108461
    [No Abstract]   [Full Text] [Related]  

  • 28. [Is essential hypertension still a disease entity? Definition of hyporeninemic hypertension].
    Distler A
    Internist (Berl); 1974 Mar; 15(3):146-54. PubMed ID: 4600300
    [No Abstract]   [Full Text] [Related]  

  • 29. [Systemic arterial hypertension: pathogentic role of the sympathetic nervous system].
    Andrejak M; Simon A; Hardin JM; Fournier A; Safar M; Quichaud J
    Nouv Presse Med; 1977 Dec; 6(42):3963-7. PubMed ID: 600739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Borderline essential hypertension and the adrenergic nervous system. Identification assay].
    Cuche JL; Guédon J
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():107-15. PubMed ID: 6794524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Approach to the etiological study of essential hypertension].
    Omae T; Tanaka K
    Naika; 1969 Oct; 24(4):604-9. PubMed ID: 4902221
    [No Abstract]   [Full Text] [Related]  

  • 33. [The renin-angiotensin system and the sympathetic nervous system in essential hypertension].
    Vincent M; Milon H; Revol T; Annat G; Froment A; Sassard J; Cier JF
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():91-4. PubMed ID: 6810836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between the renin-angiotensin-aldosterone system and CNS in the etiology of hypertension].
    Hartrodt W; Brosowski KH; Baumann R
    Dtsch Gesundheitsw; 1971 Feb; 26(6):237-43. PubMed ID: 4328786
    [No Abstract]   [Full Text] [Related]  

  • 36. [Humoral mechanisms in the pathogenesis of arterial hypertension with emphasis on the renin-angiotensin-aldosterone system and natriuretic substances].
    Horký K
    Vnitr Lek; 1989 Mar; 35(3):219-25. PubMed ID: 2525299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
    Gross F
    Adv Intern Med; 1968; 14():281-339. PubMed ID: 4303034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of central nervous system and sympathetic nervous system in essential hypertension].
    Gotoh E; Sumita S
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():285-91. PubMed ID: 11026276
    [No Abstract]   [Full Text] [Related]  

  • 39. Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism.
    Nicholls MG; Julius S; Zweifler AJ
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):253-8. PubMed ID: 6975670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Opinion in Endocrinology, Diabetes & Obesity. Editorial overview.
    Seely EW
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):187. PubMed ID: 20404725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.